ACCIÓ presents the Novartis Türkiye Health Innovation Program, a challenge-based initiative that brings together entrepreneurs, industry leaders, and public stakeholders to develop solutions to key challenges in the healthcare system. The program concludes with a Challenge Day, where selected startups present their proposals.

The challenges focus on alternative financing, cardiovascular diseases, early-stage breast cancer (eBC), spinal muscular atrophy (SMA), and urticaria, including topics such as early detection, use of artificial intelligence, treatment adherence, patient support, innovative financing models, and digital monitoring and prevention tools.

The call is open to international participation, and 10 startups will be selected for the final round. Pre-selection will take place on April 17, 2026, and the selected startups will present on June 11, 2026. The top three will have the opportunity to develop proof-of-concept (PoC) projects with Novartis Türkiye.

Startups in the fields of healthcare, life sciences, or digital health with an already developed product or solution, preferably with real-world use, are eligible to apply. Participation in program sessions is required, as well as in-person attendance at the Challenge Day in Ankara, and all presentations must be delivered in English.

Opportunity link:
https://www.tenity.com/program/novartis-turkiye-health-innovation-program/